Home › Dermatitis
Dermatitis clinical trials recruiting in the U.S.
8 studies for Dermatitis are recruiting participants at sites across the United States.
Cities with the most studies
- Birmingham, AL6 studies
- Miami, FL5 studies
- Little Rock, AR4 studies
- Huntington Beach, CA4 studies
- Los Angeles, CA4 studies
- San Antonio, TX3 studies
- Santa Clarita, CA3 studies
- Fargo, ND3 studies
- Tampa, FL3 studies
- Dallas, TX3 studies
- Lewisville, TX3 studies
By state
- Alabama6 studies
- Arizona3 studies
- Arkansas5 studies
- California6 studies
- Florida7 studies
- Georgia5 studies
- Illinois3 studies
- Maryland3 studies
- New York4 studies
- North Dakota3 studies
- Texas6 studies
Recently updated studies
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 12, 2026 · NCT07765888Effects of Treatments on Atopic Dermatitis
RecruitingPhase 2Healthy volunteers welcome
Ages 2 to 50 · All sexes · Updated Nov 12, 2026 · NCT01631617First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Nov 6, 2026 · NCT07527923Roflumilast Cream 0.3% for Moderate to Severe Atopic Dermatitis
RecruitingPhase 3
Ages 6 and older · All sexes · Updated Nov 6, 2026 · NCT07916480A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 6, 2026 · NCT07783425Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Sep 28, 2026 · NCT06947993A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 28, 2026 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
Ages 18 to 74 · All sexes · Updated Aug 12, 2026 · NCT07037901From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.